Literature DB >> 9073061

An integrated vector system for the eukaryotic expression of antibodies or their fragments after selection from phage display libraries.

L Persic1, A Roberts, J Wilton, A Cattaneo, A Bradbury, H R Hoogenboom.   

Abstract

Phage display is now an established method to select antibody fragments specific for a wide range of diverse antigens. In particular, isolation of human monoclonal antibodies has become a reality and for most purposes bacterial expression of the selected recombinant antibody fragments is sufficient. However, there are some cases where the expression of complete human immunoglobulin in mammalian cells is, if not essential, at least desirable. For this reason we have designed and constructed a set of mammalian expression vectors which permit facile and rapid cloning of antibody genes for both transient and stable expression in mammalian cells. Immunoglobulin genes may be cloned into these expression vectors as V regions or as Fabs for expression as either complete antibodies or as Fab fragments, using restriction sites which are rare in human V genes. All the important elements in the vectors--promoter, leader sequence, constant domains and selectable markers--are flanked by unique restriction sites, allowing simple substitution of elements. The vectors have been evaluated using the variable regions from the neutralizing anti-nerve growth factor (NGF) antibody, alphaD11, and the V regions from 2E10, a scFv selected from a scFv phagemid library.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9073061     DOI: 10.1016/s0378-1119(96)00628-2

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  48 in total

Review 1.  Targeting antibodies to the cytoplasm.

Authors:  Andrea L J Marschall; André Frenzel; Thomas Schirrmann; Manuela Schüngel; Stefan Dübel
Journal:  MAbs       Date:  2011-01-01       Impact factor: 5.857

2.  Probing a protein-protein interaction by in vitro evolution.

Authors:  George Thom; Alexis C Cockroft; Andrew G Buchanan; Cathy Joberty Candotti; E Suzanne Cohen; David Lowne; Phill Monk; Celia P Shorrock-Hart; Lutz Jermutus; Ralph R Minter
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-09       Impact factor: 11.205

3.  Designed auto-assembly of nanostreptabodies for rapid tissue-specific targeting in vivo.

Authors:  Philippe Valadon; Bryan Darsow; Tim N Buss; Malgorzata Czarny; Noelle M Griffin; Han N Nguyen; Phil Oh; Per Borgstrom; Adrian Chrastina; Jan E Schnitzer
Journal:  J Biol Chem       Date:  2009-10-22       Impact factor: 5.157

4.  Phage display and hybridoma generation of antibodies to human CXCR2 yields antibodies with distinct mechanisms and epitopes.

Authors:  Christine J Rossant; Danielle Carroll; Ling Huang; John Elvin; Frances Neal; Edward Walker; Joris J Benschop; Eldar E Kim; Simon T Barry; Tristan J Vaughan
Journal:  MAbs       Date:  2014       Impact factor: 5.857

5.  A peptide derived from melanotransferrin delivers a protein-based interleukin 1 receptor antagonist across the BBB and ameliorates neuropathic pain in a preclinical model.

Authors:  George Thom; Mei-Mei Tian; Jon P Hatcher; Natalia Rodrigo; Matthew Burrell; Ian Gurrell; Timothy Z Vitalis; Thomas Abraham; Wilfred A Jefferies; Carl I Webster; Reinhard Gabathuler
Journal:  J Cereb Blood Flow Metab       Date:  2018-05-30       Impact factor: 6.200

6.  Monovalent IgG4 molecules: immunoglobulin Fc mutations that result in a monomeric structure.

Authors:  Ian C Wilkinson; Susan B Fowler; Leeann Machiesky; Kenneth Miller; David B Hayes; Morshed Adib; Cheng Her; M Jack Borrok; Ping Tsui; Matthew Burrell; Dominic J Corkill; Susanne Witt; David C Lowe; Carl I Webster
Journal:  MAbs       Date:  2013-04-08       Impact factor: 5.857

7.  In vitro evolution of antibody affinity via insertional scanning mutagenesis of an entire antibody variable region.

Authors:  Kalliopi Skamaki; Stephane Emond; Matthieu Chodorge; John Andrews; D Gareth Rees; Daniel Cannon; Bojana Popovic; Andrew Buchanan; Ralph R Minter; Florian Hollfelder
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-16       Impact factor: 11.205

8.  Targeting the intracellular WT1 oncogene product with a therapeutic human antibody.

Authors:  Tao Dao; Su Yan; Nicholas Veomett; Dmitry Pankov; Liang Zhou; Tatyana Korontsvit; Andrew Scott; Joseph Whitten; Peter Maslak; Emily Casey; Taochao Tan; Hong Liu; Victoria Zakhaleva; Michael Curcio; Ekaterina Doubrovina; Richard J O'Reilly; Cheng Liu; David A Scheinberg
Journal:  Sci Transl Med       Date:  2013-03-13       Impact factor: 17.956

9.  A multi-Fc-species system for recombinant antibody production.

Authors:  Sandrine Moutel; Ahmed El Marjou; Ole Vielemeyer; Clément Nizak; Philippe Benaroch; Stefan Dübel; Franck Perez
Journal:  BMC Biotechnol       Date:  2009-02-26       Impact factor: 2.563

10.  Gephyrin selective intrabodies as a new strategy for studying inhibitory receptor clustering.

Authors:  Paola Zacchi; Elena Dreosti; Michela Visintin; Matteo Moretto-Zita; Ivan Marchionni; Isabella Cannistraci; Zeynep Kasap; Heinrich Betz; Antonino Cattaneo; Enrico Cherubini
Journal:  J Mol Neurosci       Date:  2007-11-16       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.